Your browser doesn't support javascript.
loading
Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.
Sannicolo, Sarah; Giaj Levra, Matteo; Le Gouellec, Audrey; Aspord, Caroline; Boccard, Julien; Chaperot, Laurence; Toussaint, Bertrand; Moro-Sibilot, Denis; Hannani, Dalil; Toffart, Anne-Claire.
Afiliação
  • Sannicolo S; CNRS, Grenoble INP, TIMC-IMAG, CHU de Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France; Pôle cancer et maladies du sang, CHU de Grenoble-Alpes, Grenoble, France.
  • Giaj Levra M; Unité d'oncologie thoracique, pôle thorax et vaisseaux, service hospitalier universitaire pneumologie physiologie, CHU de Grenoble-Alpes, Grenoble, France; Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Immunobiology and Immunotherapy in Chronic Diseases, Université Grenoble-Alpes
  • Le Gouellec A; CNRS, Grenoble INP, TIMC-IMAG, CHU de Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.
  • Aspord C; Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Immunobiology and Immunotherapy in Chronic Diseases, Université Grenoble-Alpes, 38000 Grenoble, France; R&D Laboratory, établissement français du sang Auvergne-Rhône-Alpes, 38000 Grenoble, France.
  • Boccard J; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
  • Chaperot L; Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Immunobiology and Immunotherapy in Chronic Diseases, Université Grenoble-Alpes, 38000 Grenoble, France; R&D Laboratory, établissement français du sang Auvergne-Rhône-Alpes, 38000 Grenoble, France.
  • Toussaint B; CNRS, Grenoble INP, TIMC-IMAG, CHU de Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.
  • Moro-Sibilot D; Unité d'oncologie thoracique, pôle thorax et vaisseaux, service hospitalier universitaire pneumologie physiologie, CHU de Grenoble-Alpes, Grenoble, France; Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Immunobiology and Immunotherapy in Chronic Diseases, Université Grenoble-Alpes
  • Hannani D; CNRS, Grenoble INP, TIMC-IMAG, CHU de Grenoble-Alpes, University Grenoble-Alpes, Grenoble, France.
  • Toffart AC; Unité d'oncologie thoracique, pôle thorax et vaisseaux, service hospitalier universitaire pneumologie physiologie, CHU de Grenoble-Alpes, Grenoble, France; Inserm U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Immunobiology and Immunotherapy in Chronic Diseases, Université Grenoble-Alpes
Respir Med Res ; 80: 100845, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34242975
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Respir Med Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Respir Med Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França